The Parkinson's disease death rate: carbidopa and vitamin B6
Marty Hinz,1 Alvin Stein,2 Ted Cole31Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, USA; 2Stein Orthopedic Associates, Plantation, FL, USA; 3Cole Center for Healing, Cincinnati, OH, USAAbstract: The only indication for carbidopa and benserazide is the management of L-3,4-dihydroxyp...
Enregistré dans:
Auteurs principaux: | Hinz M, Stein A, Cole T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/87d24a3a33724faa8d5da050db49656d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
par: Hinz M, et autres
Publié: (2021) -
Parkinson's disease: carbidopa, nausea, and dyskinesia
par: Hinz M, et autres
Publié: (2014) -
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
par: Hinz M, et autres
Publié: (2020) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
par: Hinz M, et autres
Publié: (2021) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
par: Hinz M, et autres
Publié: (2020)